Medical device and MedTech insights, news, tips and more

PENTAX Medical Launches DEC HD Duodenoscope in the United States

November 25, 2019

Pentax Duodenscope

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, has announced the United States launch of its DEC™ HD Duodenoscope, an advanced, high-definition duodenoscope that features multiple disposable components, including the sterile distal cap and elevator lever, for unit reprocessing. The DEC HD Duodenoscope is designed to provide physicians a solution aligned with recent FDA guidance on reducing endoscope reprocessing, as well as deliver tangible “Triple Aim”1 value (by improving clinical outcomes, reducing care costs, and enhancing physician and patient experiences). The device has been available in global markets since 2017 and recently received FDA clearance, facilitating its US commercial launch.

Pentax Duodenscope

Conventional duodenoscopes are linked to infection risk, despite proper reprocessing after ERCP procedures. In a recent safety communication published by the FDA, it was stated: “FDA recommends health care facilities and manufacturers begin transitioning to duodenoscopes with disposable components to reduce risk of patient infection […] The best path to reducing the risk of disease transmission by duodenoscopes is through innovative device designs, such as those with disposable components, that make reprocessing easier, more effective or unnecessary.”2

“Duodenoscopes with a disposable elevator component represent another major step toward lowering the risk of infection among patients who undergo procedures with these devices,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health.3

Responding to the FDA’s and CDC’s call for advancement in duodenoscope design to increase patient safety, PENTAX Medical developed the DEC: an advanced, hygienic endoscopic solution that maintains the imaging and handling performance physicians need during endoscopic retrograde cholangiopancreatography (ERCP) procedures.

The DEC allows physicians to simply and safely dispose of the elevator, the component most vulnerable to enteric bacteria.4 The DEC HD Duodenoscope features a sterile, disposable distal cap PLUS disposable elevator—helping to reduce the risk of bioburden remaining on conventional elevator components after reprocessing. This reduces the burden of time-intensive reprocessing (aka cleaning) as a result of fewer steps in the reprocessing process.

“The DEC represents a significant clinical innovation both in device design and patient safety due to its sterile and disposable distal end cap with integrated elevator, and also a human factors-validated approach to both reprocessing and competency-based training,” said Dr. Hudson Garrett, Global Chief Clinical Officer for PENTAX Medical. “The DEC was specifically designed in response to the evidence-based recommendations released by the FDA and CDC and represents a critical step forward in improving patient safety, reducing contamination, and optimizing endoscope reprocessing programs.”

Since its global launch, the DEC HD Duodenoscope has offered exceptional performance and advanced design. As a duodenoscope with HD imaging, it helps the endoscopist confidently diagnose, as well as visualize the mucosa in detail, identify abnormal tissue, and locate the papilla for cannulation. The DEC includes a lightweight, ergonomic control body offering comfortable handling and optimal maneuverability.

“The new detachable cap is one of the solutions to reduce the risk of bacterial contamination. This duodenoscope is a huge advancement and development for PENTAX (Medical),” said Dr. Marc Giovannini, Institut Paoli-Calmettes, Marseille, France.

All DEC™ HD Duodenoscopes are protected by the proactive and cost-saving PENTAX ServiceWorks™ program providing customers Access to board-certified Infection Preventionists and Patient Safety Professionals, Certified Field Reprocessing Professionals, and accredited continuing education programs to assist Healthcare Providers and Facilities in meeting evidence-based standards, clinical guidelines, and regulatory/accreditation requirements.5

See Full Press Release: PENTAX Medical Launches DEC™ HD Duodenoscope in the United States | Business Wire

Written by: PENTAX Medical

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.